Pharmaceuticals and Biotech | Media Room

Press Release Oct 2, 2023

Rancho Biosciences to Showcase Cutting-Edge Data Science Services at BioTechX Europe’s Largest Pharmaceutical Development and Healthcare Event, Oct. 4-6

Press Release Oct 2, 2023

PharmaLink Launches a DSCSA Compliant Solution for Retail and Hospital Markets

Press Release Sep 28, 2023

Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD

Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets for Treating Diabetes”, will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow". Read More

Press Release Sep 28, 2023

Rancho Biosciences Will Be Exhibiting at the Festival of Genomics & Biodata 2023

Press Release Sep 28, 2023

Amplity Health Appoints Kevin Murphy as New Head of Account Development

Appointment comes during accelerating growth of Amplity’s leading global medical and commercial franchise Read More

Press Release Sep 27, 2023

Live Forever Health Launches www.liveforeverlab.com: the Ultimate Destination for Comprehensive Lifestyle, Wellness, Hormone, and Fitness Solutions

Press Release Sep 27, 2023

Announcing Kivo GO: An Intuitive DMS to Accelerate Speed-to-Market for Life Sciences

Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams. Read More

Press Release Sep 27, 2023

Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs

Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy. Read More

Press Release Sep 26, 2023

Rancho BioSciences Collaborates to Standardize UK Biobank Clinical Data for Improved Genetic Analysis

Press Release Sep 21, 2023

Unboxed Training & Technology Receives LTEN Excellence Award for Learning Content

Press Release Sep 21, 2023

Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells

Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran Total venture funding tops $50M to date Read More

Press Release Sep 19, 2023

First Patient Treated in Innovative Clinical Study 'Amelia-1', Testing the Novel Investigational Drug Evexomostat Plus a PI3K Inhibitor in Late-Stage Breast Cancer Patients

Amelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment. Read More

Press Release Sep 19, 2023

Nostics Appoints Medtech Leader Jeroen Nieuwenhuis as CEO

Press Release Sep 19, 2023

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery

Press Release Sep 19, 2023

LighthouseAI Introduces Automated Business Change Management to Simplify Pharmaceutical Supply Chain Compliance

New Module Automates Regulatory Updates During Corporate Transitions Read More

Press Release Sep 14, 2023

SciTech Development Announces IRB Approval for Human Clinical Trials

Lead cancer drug candidate, ST-001 nanoFenretinide, has received Institutional Review Board ("IRB") approval for its upcoming clinical trials for T-Cell Lymphomas. Read More

Press Release Sep 14, 2023

New Cell & Gene Therapy Solutions From Form Bio Analyze Billions of Potential Construct Candidates, Reducing Time-to-Clinic

Powerful New Solutions Help Therapeutic Developers Reduce Time-to-Clinic While Increasing Yield and Safety Read More

Press Release Sep 13, 2023

Serve You Rx Transforms Pharmacy Benefit Management With New Client-Centered Branding Strategy

Pharmacy benefit manager's new brand pillars leverage strengths to better serve their partners and clients. Read More

Press Release Sep 12, 2023

New US Prescription Drugs Cost Now More Than $200K on Average

Ongoing rise in customers ordering Rx medication from Pharmacies like Canada Pharmacy Read More

Press Release Sep 12, 2023

CARDIO inCode Study Results Presented at ESC Annual Meeting

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode as method to target treatment Read More

Press Release Sep 12, 2023

Brainify.AI Joins Johnson & Johnson Innovation JLABS

Brainify.AI, an innovative company leveraging artificial intelligence to revolutionize the treatment of depression, is excited to announce it has joined Johnson & Johnson Innovation JLABS (JLABS) as a resident company. This marks a significant milestone for Brainify.AI and is another indication of the value and promise the company brings to the medical AI field. Read More

Press Release Sep 11, 2023

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research

Press Release Sep 7, 2023

Introducing the ONI Training Kit (TM) dSTORM

A leap into simplifying Super-Resolution Microscopy Read More

Press Release Sep 6, 2023

Minaris Regenerative Medicine Selects Apprentice.io's Tempo Manufacturing Execution System to Scale Commercial Production

Press Release Sep 5, 2023

Milestone Achievement: Waypoint GPS Assists Dr. Stephen Banco in Groundbreaking First-in-Man Spine Surgery

Press Release Sep 5, 2023

Tribun Health Secures €15 Million Euros in Series B Funding Round Led by Autonomous Patient Fund of Bpifrance With LBO, Owkin and Vivalto Family as Prominent Investors

Press Release Aug 30, 2023

Healing the Wounds of Inflammatory Bowel Disease

A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a discovery that may have direct application to humans with inflammatory bowel disease. These early findings, made possible with seed funding from the GI Research Foundation, resulted in a recent five-year, $2.5 million grant from the National Institutes of Health to study those cells in humans. Read More

Press Release Aug 28, 2023

HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

Press Release Aug 25, 2023

Ischemix, Inc. Completes Successful Phase 1 Trial of Novel Compound to Treat Traumatic Brain Injury (TBI); Preparing for Conduct of Phase 2 Trial

CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translational studies. CMX-2043 will be Phase 2-ready by the first quarter of 2024. Read More

Press Release Aug 24, 2023

Granger Health Announces Acquisition of Medical Device and Data Analytics Company

Press Release Aug 24, 2023

assisTek Announces Updated CORE Platform Release for Fall 2023

PA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions. Read More

Press Release Aug 22, 2023

Enalare Therapeutics Selected to Present at Three Upcoming Scientific Conferences Regarding Its Lead Compound, ENA-001

Press Release Aug 18, 2023

Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects

Press Release Aug 17, 2023

WholisticResearch Reveals the Best Nootropics of 2023

In-depth Analysis and Testing Unveil the Leading Brain-Boosting Supplements Read More

Press Release Aug 17, 2023

Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians Read More

Press Release Aug 16, 2023

For the 3rd Year in a Row, Just in Time GCP Makes the Inc. 5000, Ranking No. 2813

Just in Time GCP named among Best Workplaces by Inc. Magazine Read More

Press Release Aug 16, 2023

Native Cardio Inc. Welcomes Steve Adler as New CEO — Medical Device Company Poised to Enter the Atrial Fibrillation Market

Press Release Aug 16, 2023

Eden Radioisotopes, LLC Notifies the US Nuclear Regulatory Commission of Plans to Submit License Applications to Construct and Operate a Medical Isotope Production Facility

Press Release Aug 15, 2023

Apprentice Announces Major Tempo Manufacturing Cloud Release Built to Support Commercial Manufacturing of the Future

Updates to Tempo's Manufacturing Execution System and Connected Manufacturing Network Drive Greater Efficiency and Scalability Read More

Press Release Aug 15, 2023

Form Bio Announces Executive Webinar Featuring BCG, ElevateBio, and NVIDIA

Data Science Meets Life Science: AI Challenges & Opportunities in Biopharma, Synthetic Biology and Beyond Read More

Press Release Aug 15, 2023

Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical Leaders and Researchers

Press Release Aug 14, 2023

GeneTex Addresses GPCR Targets With Its Recombinant Monoclonal Antibody Production Platform

Press Release Aug 14, 2023

Lactiga Receives FDA 'Rare Pediatric Disease' Designation for Groundbreaking Mucosal Immunoglobulin Therapy for Common Variable Immunodeficiency Disease

LCTG-001 on course to be the first FDA-approved biologic from human milk Read More

Press Release Aug 11, 2023

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays. Read More

Press Release Aug 10, 2023

Elixia Health Enters Phase I Clinical Trials Market

Tampa-based site expands study capabilities and patient comfort Read More

Press Release Aug 8, 2023

LighthouseAI Secures $2.25M Investment Led by Healthy Ventures, Innovating Pharmaceutical Supply Chain Compliance

Funding Accelerates the Development of Compliance Automation Solutions Read More

Press Release Aug 8, 2023

CanariaBio Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination With Niraparib in the Treatment of Recurrent Ovarian Cancer

Press Release Aug 3, 2023

CustomerInsights.AI Recognized in Gartner's 2023 Hype Cycle for Data & Life Sciences Commercial Operations

Press Release Aug 1, 2023

iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. Read More

Press Release Jul 27, 2023

Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients

OMO-103 in Phase 1b clinical trial Read More

Press Release Jul 25, 2023

BioPharma Connections Adds LGM Pharma as a Strategic Client Partner

LGM Pharma opts to engage with BioPharma Connections for business development services Read More

Press Release Jul 24, 2023

HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA Read More

Press Release Jul 20, 2023

LabWare Selected as Honoree of 2023 Drexel LeBow Analytics 50 Award

LabWare honored for analyzing business challenges, creating a solution and impacting the industry Read More

Press Release Jul 18, 2023

Oxford Biomedica Implements Sapio Sciences' Electronic Laboratory Notebook

Sapio's No-Code ELN to Provide Enhanced Collaboration, Unified Data Access, and Flexible Workflows to viral vector CDMO Oxford Biomedica Read More

Press Release Jul 18, 2023

Oxford Biomedica Implements Sapio Sciences' Electronic Laboratory Notebook

Sapio's No-Code ELN to Provide Enhanced Collaboration, Unified Data Access, and Flexible Workflows to viral vector CDMO Oxford Biomedica Read More

Press Release Jul 14, 2023

POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

Press Release Jul 12, 2023

AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients

Press Release Jul 11, 2023

Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge

The Parkinson's disease market is expected to grow to $12.8 billion by 2028. Read More

Press Release Jul 6, 2023

NatureMetrics Adopts Sapio Science's No-Code LIMS/ELN Platform to Accelerate Environmental DNA Monitoring

Sapio LIMS/ELN Provides NatureMetrics With a Configurable Workflow and Data Solution That Adapts as eDNA Technology Rapidly Evolves Read More

Press Release Jun 29, 2023

The Methodical Group Named 50 Fastest Growing Companies of 2023

Accelerating Industry Standards: The Methodical Group Secures Spot as One of the 50 Fastest Growing Companies of 2023, Pioneering Breakthrough Solutions Across Multiple Sectors Read More